EOS imaging Announces First Installation in the Dallas-Fort Worth Area
March 24 2015 - 12:53PM
Business Wire
Company’s strong program at the AAOS 2015
annual meeting to support ongoing US expansion
Regulatory News :
EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI), the
pioneer in 2D/3D orthopedic medical imaging, today announced the
installation of the first EOS system at a hospital in the
Dallas-Fort Worth area. This installation marks the second medical
facility in Texas to adopt low dose 2D/3D imaging achieved with the
EOS system. The Company also announced its participation at the
American Academy of Orthopedic Surgeons (AAOS) Annual Meeting,
taking place March 24-28 in Las Vegas, where it will launch its
newly released hipEOS surgical planning software.
The newly installed EOS system will serve pediatric and adult
patients in the Dallas-Fort Worth area suffering from spinal
deformities and degenerative spine, hip and knee conditions.
Dr. Isador Lieberman, M.D., M.B.A., FRCSC of the Texas Back
Institute said, “As an orthopedic surgeon my goal is to provide the
most appropriate and least invasive care to improve the condition
and quality of life of the patients with whom I work. I am thrilled
that local patients now have access to the unique benefits of the
EOS system, which reduces the radiation dose during imaging
sessions while also providing clinically superior diagnostic
results.”
Marie Meynadier, CEO of EOS imaging, said, “We are pleased that
a key orthopedic center in the Dallas-Fort Worth area has selected
EOS imaging to support its leadership position in orthopedics. This
installation demonstrates the growing interest in the U.S. for low
dose 2D/3D orthopedic imaging as the adoption of EOS continues to
increase throughout the region and the country.”
In addition to the adoption of the EOS system in Texas, EOS
imaging has a robust agenda at AAOS 2015, where the Company will
exhibit and host an educational symposium to support the official
launch of hipEOS in the U.S. AAOS is the largest international
orthopedic meeting, attracting more than 14,000 domestic and
international orthopedic surgeons and healthcare providers.
The EOS® system provides full-body stereo-radiographic images of
patients in functional positions, in both 2D and 3D. EOS exams
require a radiation dose 50% to 85% less than Digital Radiology and
95% less than basic CT scans. The new EOS Micro Dose option,
recently cleared by the Food and Drug Administration, allows a
further drastic step towards the ALARA (As Low As Reasonably
Available) principle by bringing pediatric spine follow up exams at
a dose level equivalent to a week of natural background radiation
on Earth.
EOS imaging Exhibition Booth# 5222 at AAOS | March 24-28,
2015: Visitors are invited to learn more about the EOS
technology, view live hipEOS demonstrations and discover how the
software can help surgeons perform pre-surgical planning using EOS’
unique stereo-radiographic 2D/3D low dose images.
For further information about the Company or EOS®, the first
full body, low dose 2D/3D imaging system, please visit
http://www.eos-imaging.com/.
EOS imaging has been chosen to be included in the new
EnterNext© PEA-PME 150 index, composed of 150 French companies and
listed on Euronext and Alternext markets in Paris.
EOS imaging is listed on Compartment C of Euronext ParisISIN:
FR0011191766 – Ticker: EOSI
Next press release: annual results for 2014 and turnover for the
1st quarter of 2015: on April 20, 2015 (after market).
About EOS imaging:EOS imaging designs, develops, and
markets EOS®, an innovative medical imaging system based on
technology that enabled George Charpak to win the Nobel Prize for
Physics, as well as associated solutions. The Company is authorized
to market in 47 countries, including the United States (FDA), Japan
and the European Union (EU). As of December 31, 2014 the Group
posted 2014 consolidated revenue of €20.1 million and employed 107
people including an R&D team of 39 engineers. The Group is
based in Paris and holds four subsidiaries in Besançon (France),
Cambridge (Massachusetts), Montreal (Canada) and Frankfurt
(Germany), and offices in Singapore.
EOS imagingAnne Renevot, Ph: +33 (0)1 55 25 61
24CFOinvestors@eos-imaging.comorNewCapFinancial
communication and investor relationsAntoine Denry/ Pierre Laurent,
Ph: +33 (0)1 44 71 94 91eosimaging@newcap.frorThe Ruth Group
(US)Press relations / Calvin Allen, Ph:
646-536-7002callen@theruthgroup.com
Eos (CE) (USOTC:EOSI)
Historical Stock Chart
From Apr 2024 to May 2024
Eos (CE) (USOTC:EOSI)
Historical Stock Chart
From May 2023 to May 2024